Ansa Raises 71 5 Million to Scale Long DNA Synthesis

Ansa Biotechnologies announced a $71.5 million Series C led by Blue Water Life Science Advisors, bringing company-reported cumulative funding to $211 million. It plans to scale enzymatic synthesis of long, complex DNA for research,…




